Literature DB >> 1884736

Prescription of drugs not listed in a clinic's pharmacopoeia: supervision by clinical pharmacologists.

S Harder1, P Thürmann, T Huber, N Rietbrock.   

Abstract

The pharmaceutical market in the FRG offers about 11,000 different preparations and formulations. A restricted list (pharmacopoeia) containing approximately 1,000 drugs has been proved to cover the routine requirements of a university clinic and most of the additional drugs demanded by the physicians as 'exceptis excipiendis'. Restrictive control of requests for drugs not included in the internal pharmacopoeia by clinical pharmacologists has reduced the absolute number of requests by half, and about 60% of the remaining requests could be replaced by drugs listed in the pharmacopoeia. The majority of the special requests arose from the continuation of drugs presented to out-patients by the resident physicians after admission of the patient to the hospital. The supervision may lead to more critical revision of out-patient medication, but a substantial reduction of drug expenditure was not attained, as the drugs requested amounted only to a minor fraction of the overall drug expenditure by the hospital.

Entities:  

Mesh:

Year:  1991        PMID: 1884736     DOI: 10.1007/bf00279970

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

Review 1.  [Drug commission--experiences at a university clinic].

Authors:  F Hartmann
Journal:  Internist (Berl)       Date:  1990-07       Impact factor: 0.743

2.  Hospital formularies: need for continuous intervention.

Authors:  J Feely; R Chan; L Cocoman; K Mulpeter; P O'Connor
Journal:  BMJ       Date:  1990-01-06

3.  The risks of substitution of therapeutic modalities by cheaper and sometimes less effective agents.

Authors:  I Brook
Journal:  Arch Intern Med       Date:  1990-03

4.  Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe.

Authors:  G Dukes; P K Lunde; A Melander; M Orme; F Sjöqvist; G Tognoni; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  [Drug lists for hospitals--how do they originate and of what use are they?].

Authors:  H Kewitz
Journal:  Internist (Berl)       Date:  1986-01       Impact factor: 0.743

6.  Seventeen years' experience of a voluntarily based drug rationalisation programme in hospital.

Authors:  J A Baker; A F Lant; C A Sutters
Journal:  BMJ       Date:  1988-08-13

7.  Limited lists of drugs: lessons from abroad.

Authors:  T Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16

8.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

9.  Do prescribed drugs always follow the patients to hospital?

Authors:  P A Van Hessen; H Petri; J Urquhart
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

10.  Drug utilization by the 30-64 year-old people in two cities in the Federal Republic of Germany in 1984.

Authors:  P Tennis
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more
  4 in total

1.  Determinants of hospital drug expenditures in Western Europe.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

2.  [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].

Authors:  S Harder; P Thürmann; A Steioff
Journal:  Med Klin (Munich)       Date:  1998-02-15

3.  Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany.

Authors:  Sebastian Harder; Philipp Fischer; Markus Krause-Schäfer; Klaus Ostermann; Gottfried Helms; Helge Prinz; Mike Hahmann; Horst Baas
Journal:  Eur J Clin Pharmacol       Date:  2004-12-01       Impact factor: 2.953

4.  The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study.

Authors:  Thomas Grimmsmann; Ulrike Schwabe; Wolfgang Himmel
Journal:  Eur J Clin Pharmacol       Date:  2007-06-05       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.